MedTrace Logo

Guaranteed Income and Financial Treatment

NCT06611982 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2026-03-25

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if providing advanced cancer patients with $1000/month for 12 months will improve cancer outcomes. The main questions it aims to answer are:

To what extent does receiving $1000/month additional income reduce financial hardship? To what extent does receiving $1000/month additional income improve quality of life? Does receiving $1000/month additional income improve survival outcomes?

Participants will:

Receive $1000/month for 12 months Complete a survey every 3 months for 12 months If selected, participate in semi-structured interviews about their financial behaviors

Conditions

  • Cancer
  • Financial Hardship
  • Quality of Life

Interventions

OTHER

Unconditional cash transfer

$1000/month for 12 months

OTHER

Contact information for social worker and financial counselor

Information on financial toxicity and contact information for social worker and financial counselor

Sponsors & Collaborators

  • Mathematica Policy Research, Inc.

    collaborator OTHER

  • Meredith Doherty, PhD, LCSW

    lead OTHER

Principal Investigators

  • Meredith Doherty · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-07-30
Completion
2026-07-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06611982 on ClinicalTrials.gov